I am interested in partnering with you as a licensee/licensor, how do I get in touch
Sousa-Lima I, Fernandes AB, Patarro RS, Kim Y-B, Macedo MP
Learn more at Medicare.gov enrollment periods
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
Characterization of artificially re-pigmented ARPE-19 retinal pigment epithelial cell model
NAD+ IM NAD+: The cellular rejuvenator NAD+ (Nicotinamide Adenine Dinucleotide) is a crucial coenzyme found in every cell that plays a vital role in energy metabolism, DNA repair, and cellular health